Treatment Decision-making in Patients With Recurrent High-grade Glioma
Recurrent High-grade Glioma: Experiences of Patients and Their Close Relatives During the Treatment Decision-making Process.
Sponsor: Danish Cancer Society
Listed as NCT04013828, this observational or N/A phase trial focuses on Life Experiences and Malignant Glioma and remains completed. Sponsored by Danish Cancer Society, it has been updated 6 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Oct 2021 — May 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 1 earlier version
-
Aug 2019 — Jan 2021 [monthly]
Recruiting
First recorded
May 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Danish Cancer Society
- Novo Nordisk A/S
- Odense University Hospital
- Region of Southern Denmark
- Rigshospitalet, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .